EQUR

E-Qure Corp. [EQUR] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

EQUR Stock Summary

In the News

EQUR Financial details

Company Rating
-
Market Cap
6.91K
Income
-822.6K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
17 Dec 2020
P/E
-0.01
Forward P/E
-
PEG
-0.02
P/S
-
P/B
-0.02
P/C
-
P/FCF
-0.02
Quick Ratio
0.17
Current Ratio
0.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
30.47%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-712%
ROE
175%
ROC
1.62%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.0E-4-0.0499
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
286
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.14967
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
NVDA
LLY.DE
BRK-B
MIX.JO
ABEA.DE
Same Sector
OPHLF
CNCE
EVIO
1521.HK
SNW.DE
Check Those
MBII
SAGO.ME
6703.T
CWBK
YAHOY
Similar Market Cap
PRPM
FTMRQ
LSAI.L
EQUR
LXAM

Company Profile

Healthcare Medical - Devices
  • Volume Average 286
  • Market Capitalization 6.91K
  • Employee 1
  • CEO Mr. Ohad Goren
  • Headquarters New York,NY,US
  • IPO Date 1994-10-31
  • Website https://www.e-qure.com

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.